Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | KDM6B | O15054 | 1/20 | 0.43 |
| ▸ | KDM5C | P41229 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16879073 | 1.00 | — | — | |
| Zinc Ion SCHEMBL28870514 | 0.92 | — | — | |
| SCHEMBL9791280 | 0.92 | MGAM (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL6415978 | 0.92 | MGAM (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL11058910 | 0.92 | MGAM (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL2128645 | 0.91 | MGAM (0.56) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL10389469 | 0.91 | MGAM (0.56) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL1608 | 0.91 | — | — | |
| Water SCHEMBL23151837 | 0.87 | MGAM (0.53) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL21404928 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534650-B2 | Composition for preparing a release coating and method of preparing coated substrate | DOW SILICONES CORPORATION (US) | 2026-01-27 | — | — | US | disclosed |
| US-20240271016-A1 | COMPOSITION FOR PREPARING A RELEASE COATING AND METHOD OF PREPARING COATED SUBSTRATE | DOW GLOBAL TECHNOLOGIES LLC | 2024-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534650-B2 | Composition for preparing a release coating and method of preparing coated substrate | COL2A1, MSR1, COL1A1 | MGAM 2206/4885GAA 879/4885SI 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.